May 8, 2023· Comment from National Association of Chain Drug Stores, HHS_FRDOC_0001, HHS_FRDOC_0001-0885, 2023-03012· SAMHSA-2023-0001-0083
Please see the attached comments of the National Association of Chain Drug Stores relating to: 1) the Notice of Proposed Rulemaking for Medication for the Treatment of Opioid Use Disorder published for public comment on December 16, 2022; and 2) the subsequent Supplemental Notice of Proposed Rulemaking on Medications for the Treatment of Opioid Use Disorder and Removal of the DATA 2000 Waiver Requirements published for comment on February 13, 2023. We appreciate SAMHSA considering our comments on this matter.